Search results

34 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC Pulmonary Diseases and Critical Care Medicine: A Comprehensive Approach
In the recent U.S. News and World Report rankings of America’s Best Hospitals, UNC Hospitals was nationally ranked in five of the 16 specialties. In this series, we profile these specialties to learn more about what makes them so outstanding.
Located in News / 2015 / September
Five genetic regions implicated in cystic fibrosis severity
An international consortium of researchers conducted the largest-ever CF genome-wide analysis to find new therapeutic targets.
Located in News / 2015 / September
A "Fitbit" For Better Lung Function
Two UNC School of Medicine students team up with peers at Duke and NC State to create a device to help COPD patients improve lung function, track their health, and provide data for doctors.
Located in News / 2015 / October
A Grand Opening
With the dedication of Marsico Hall, UNC ushered in a new era of medical research, collaboration, and promise for the people of North Carolina and beyond.
Located in News / 2014 / March
UNC researchers find genetic trigger for RSV-induced infant hospitalizations
The discovery could lead to new therapies and better diagnostics, resulting in fewer hospitalizations of children with respiratory syncytial virus, the leading cause of severe lung infection in babies.
Located in News / 2014 / April
Increased mucins pinned to worsening cystic fibrosis symptoms
The discovery from UNC School of Medicine researchers overturns a controversial research study and offers a path for creating and testing CF treatments.
Located in News / 2014 / June
UNC researchers find unsuspected characteristics of new CF drugs, offering potential paths to more effective therapies
The study, led by Martina Gentzsch, PhD, provides evidence that could help drug developers improve compounds aimed at correcting CFTR proteins in cystic fibrosis patients.
Located in News / 2014 / July
UNC awarded $6.25 million renewal grant by NIH Rare Diseases Research Network
The University of North Carolina at Chapel Hill has been awarded a five-year, $6.25 million renewal grant to continue its work as part of the National Institutes of Health’s Rare Diseases Clinical Research Network (RDCRN).
Located in News / 2014 / October
Two UNC doctors participating in Ebola clinical trial
William A. Fischer II and David Wohl are taking part in a clinical trial at ELWA Hospital in Monrovia, Liberia, in which plasma from survivors of Ebola virus disease is given to patients who are battling the disease.
Located in News / 2014 / December
UNC's Fischer one of 'the ones who answered the call'
TIME magazine selected Ebola Fighters as their Person of the Year 2014. We are proud that William A. Fischer II, MD, from the UNC School of Medicine was one of "the ones who answered the call."
Located in News / 2014 / December